3087 CDGSH iron-sulfur domains
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Benzenoids | 1 | 0.2 | 4.62× | not tested | |
| Organic oxygen compounds | 1 | 0.6 | 1.70× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.6 | 1.57× | not tested | |
| Homogeneous metal compounds | 1 | 1.5 | 0.69× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB09459 | TLA | L-tartaric acid | 2 |
| DB00695 | FUN | Furosemide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FES | FE2/S2 (INORGANIC) CLUSTER | 76 |
| CDL | CARDIOLIPIN | 8 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 6 |
| 49I | 2-benzamido-4-[(2~{R})-1,2,3,4-tetrahydronaphthalen-2-yl]thiophene-3-carboxylic acid | 5 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 4 |
| 4OY | 2-benzamido-4-[(2~{S})-1,2,3,4-tetrahydronaphthalen-2-yl]thiophene-3-carboxylic acid | 2 |
| TLA | L(+)-TARTARIC ACID | 2 |
| ZNmetal | ZINC ION | 2 |
| CL | CHLORIDE ION | 1 |
| FUN | 5-(AMINOSULFONYL)-4-CHLORO-2-[(2-FURYLMETHYL)AMINO]BENZOIC ACID | 1 |